Skip to content

Released May 7, 2020, before the open

10-Q filed May 7, 2020, 37 days after period end · 0001104659-20-057762

Q1 2020 · 10-Q
Revenue—
Net Income-$5.77MN/M vs Q1 2019N/M vs Q4 2019
EPS Diluted-$0.14N/M vs Q1 2019no prior Q4 2019 on file
Operating Income-$4,597,015N/M
Operating Cash Flow-$3,376,262N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2020Q1 2019Q1 2018Q1 2017
Revenue—$0.00$428.03K$0.00
Net Income-$5.77M-$3.22M-$2.72M-$4.86M
EPS Diluted-$0.14-$0.14-$0.13-$0.26

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR